NCT05366400 is a clinical trial of ECHO in COPD, sponsored by Damanhour University.

Who is sponsoring NCT05366400?

NCT05366400 is sponsored by Damanhour University.

What drugs are being tested in NCT05366400?

Interventions in NCT05366400: ECHO.

What condition does NCT05366400 study?

NCT05366400 studies COPD, Right Heart Failure.

Is NCT05366400 still recruiting?

NCT05366400 is currently completed. Last updated 19 May 2023.

Last reviewed 2023-05-19 · How we verify

NCT05366400

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relationship Between Right Atrial Volume Index, Functional Capacity and Inflammatory Biomarkers in Patients With COPD.

Completed Last updated 19 May 2023

What this trial tests

trial testing ECHO in COPD in 151 participants. Completed in 1 September 2022.

Timeline

19 January 2022

Primary endpoint
30 August 2022

1 September 2022

Quick facts

Lead sponsor	Damanhour University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	151
Start date	19 January 2022
Primary completion	30 August 2022
Estimated completion	1 September 2022
Sites	1 location across Egypt

Drugs / interventions tested

ECHO

Conditions studied

COPD — all drugs for COPD →
Right Heart Failure — all drugs for Right Heart Failure →

Sponsor

Damanhour University

Who can join

Adults 18 to 60, any sex, with COPD or Right Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Right ventricular (RV) dysfunction is associated with increased morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD). Assessment of RV function by echocardiography is challenging. Easy visualization of the right atrium (RA) by echocardiography , allows quantitative, highly reproducible assessment of RA volume. The aim of the present study is to evaluate the relationship between the right atrial volume index (RAVI) and functional capacity in patients with COPD , quantified by the COPD assessment test (CAT) questionnaire as an early predictor of right heart affection.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Functional capacity and inflammatory biomarkers as predictors for right atrial volume index in COPD patients.
Khedr L, Khedr NF, Werida RH. · · 2023 · cited 2× · PMID 37217717 · DOI 10.1007/s10554-023-02871-5

Verify or expand the search:

Other trials of ECHO

Trials testing the same drug.

NCT07149883 — Evaluation of Mean Platelet Volume and Systemic Inflammatory Response Index (SIRI) in Patients of Acute Coronary Syndrom · not yet recruiting
NCT06492473 — Clinical Evaluation Of Ventricular Septal Defect (VSD) In Children at Sohag Univesity Hospital · recruiting
NCT05371054 — Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies · Phase 1, PHASE2 · completed
NCT04933617 — Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas · Phase 1 · terminated
NCT04363320 — Fostering MAT Use in Justice Populations · NA · completed

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Other Damanhour University trials

Trials by the same sponsor.

NCT07307911 — Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy · Phase 2 · completed
NCT07341893 — Sacubitril-valsartan in Patients With Heart Failure. · NA · recruiting
NCT07063628 — Triglyceride-Glucose Indices and Left Ventricular Speckle Tracking in Predicting Coronary Artery Disease Severity · completed
NCT06849388 — Effect of HeartMath Intervention on Stress, Emotional Vitality and Sense of Coherence · NA · recruiting
NCT07179302 — Pre- and Post-TAVI Patient Assessment: Advancing Outcome Precision in Aortic Valve Therapy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05366400 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Damanhour University
Last refreshed: 19 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05366400.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing